https://eluminexbio.com/eluminex-biosciences-expands-leadership-team-and-receives-award/ 2021-07-24T00:34:43+00:00 https://eluminexbio.com/eluminex-successfully-held-its-grand-opening-ceremony/ 2021-10-30T02:16:36+00:00 https://eluminexbio.com/wp-content/uploads/elementor/thumbs/Office-scaled-pfajfivcdndjg7hgx0juzngizur8czlclrdj0gpiyy.jpg https://eluminexbio.com/wp-content/uploads/Display-Area.jpg https://eluminexbio.com/wp-content/uploads/elementor/thumbs/Lab-pfajfivcdndjg7hgx0juzngizur8czlclrdj0gpiyy.jpg https://eluminexbio.com/wp-content/uploads/Group-Photo-1024x683.jpg https://eluminexbio.com/wp-content/uploads/WeChat-Image_20211017173452-7.jpg https://eluminexbio.com/eluminex-ceo-was-invited-as-a-guest-speaker-at-the-devicechina-2021-and-a-panelist-at-the-china-healthcare-summit/ 2021-12-30T23:06:16+00:00 https://eluminexbio.com/wp-content/uploads/mmexport1637137763612-1024x768.jpg https://eluminexbio.com/wp-content/uploads/%E5%BE%AE%E4%BF%A1%E5%9B%BE%E7%89%87_20211227091159-1024x768.jpg https://eluminexbio.com/eluminex-further-expands-leadership-team-and-receives-new-awards/ 2022-01-05T05:44:52+00:00 https://eluminexbio.com/eluminex-biosciences-successfully-completes-its-first-pre-ind-meeting-with-the-united-states-food-and-drug-administration-for-a-multivalent-fc-fusion-protein-eb-101-for-the-treatment-of-neovascular/ 2022-01-17T04:02:47+00:00 https://eluminexbio.com/eluminex-biosciences-acquires-zuretinol-acetate-from-retinagenix-holdings/ 2022-01-19T16:01:25+00:00 https://eluminexbio.com/eluminex-biosciences-exclusively-licenses-fibrogens-biosynthetic-cornea-technology-and-recombinant-collagen-iii-platform/ 2022-01-19T16:08:28+00:00 https://eluminexbio.com/eluminex-biosciences-closes-50-million-series-a-financing/ 2022-01-19T16:13:42+00:00 https://eluminexbio.com/eluminex-announces-completion-of-enrollment-in-part-a-of-the-clarity-study/ 2023-02-27T22:11:54+00:00 https://eluminexbio.com/eluminex-biosciences-closes-40-million-series-b-financing/ 2023-02-28T03:26:08+00:00 https://eluminexbio.com/zh-hans/%e4%ba%ba%e7%89%a9%e9%a3%8e%e9%87%87%e4%b8%a8%e5%85%b8%e6%99%b6%e7%94%9f%e7%89%a9%e5%bc%a0%e9%87%91%e5%bf%a0%ef%bc%9a%e4%bc%9f%e5%a4%a7%e7%9a%84%e4%bc%81%e4%b8%9a%e6%ba%90%e4%ba%8e%e4%bd%bf%e5%91%bd/ 2023-03-26T03:39:37+00:00 https://eluminexbio.com/eluminex-biosciences-announces-acceptance-of-three-abstracts-at-upcoming-2023-arvo-and-ascrs-annual-ophthalmology-meetings-regarding-the-eb-301-biosynthetic-cornea-program/ 2023-04-10T01:06:17+00:00 https://eluminexbio.com/eluminex-biosciences-receives-scientific-recognition-for-its-recombinant-human-collagen-rhciii-biosynthetic-cornea-eb-301-program-to-treat-corneal-blindness/ 2023-05-17T16:24:11+00:00 https://eluminexbio.com/eluminex-biosciences-completes-series-b-financing-raising-more-than-50-m-in-2023/ 2023-08-21T18:37:34+00:00 https://eluminexbio.com/eluminex-biosciences-announces-fda-acceptance-of-investigational-new-drug-ind-application-for-eb-105-a-novel-trispecific-fusion-antibody-for-diabetic-macular-edema-dme-and-upcoming-scientific/ 2024-04-30T17:54:59+00:00 https://eluminexbio.com/eluminex-biosciences-announces-first-patient-dosed-in-the-phase-1b-lotus-trial-of-the-novel-trispecific-fusion-antibody-eb-105-in-diabetic-macular-edema-dme/ 2024-07-16T00:29:05+00:00 https://eluminexbio.com/eluminex-biosciences-announces-phase-1b-single-ascending-dose-study-results-of-a-novel-pentavalent-trispecific-fusion-antibody-eb-105-in-patients-with-diabetic-macular-edema-dme/ 2025-07-01T21:58:06+00:00